Reports a rare case of a de novo TNNI3 mutation presenting with both ventricular septal defect and restrictive cardiomyopathy, suggesting an overlap of functional and morphologic phenotypes in sarcomeric genes.
Answers are grounded in this paper and cite their sources.
Leaves open whether TNNI3 testing should guide pediatric cardiomyopathy management; supports further investigation of sarcomeric overlap with congenital defects.
Here, we report an infantile case of ventricular septal defect and restrictive cardiomyopathy caused by a de novo mutation of the cardiac troponin T gene. Initially diagnosed with a perimembranous ventricular septal defect in the newborn period, we observed the first signs of restrictive cardiomyopathy at the age of 18 months. The patient was listed for cardiac transplantation at the age of 8 years despite optimal medical treatment. The finding of a de novo mutation in TNNI3 (R204H) enabled a genetic diagnosis and counselling. We suggest that the previously reported overlap of functional and morphologic phenotypes in sarcomeric genes may also be a feature of TNNI3 mutations.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: